XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue recognition and accounts receivable (Tables)
9 Months Ended
Sep. 30, 2021
Revenue Recognition And Accounts Receivable [Abstract]  
Schedule of Net Sales by Major Product Category by Reporting Segment

The table below presents net sales by major product category by reporting segment:

 

 

 

Three Months Ended September 30,

 

(U.S. Dollars, in thousands)

 

2021

 

 

2020

 

 

Change

 

Bone Growth Therapies

 

$

45,168

 

 

$

47,066

 

 

 

-4.0

%

Spinal Implants

 

 

28,151

 

 

 

25,505

 

 

 

10.4

%

Biologics

 

 

12,806

 

 

 

15,245

 

 

 

-16.0

%

Global Spine

 

 

86,125

 

 

 

87,816

 

 

 

-1.9

%

Global Orthopedics

 

 

26,303

 

 

 

23,169

 

 

 

13.5

%

Net sales

 

$

112,428

 

 

$

110,985

 

 

 

1.3

%

 

 

 

 

Nine Months Ended September 30,

 

(U.S. Dollars, in thousands)

 

2021

 

 

2020

 

 

Change

 

Bone Growth Therapies

 

$

137,821

 

 

$

120,888

 

 

 

14.0

%

Spinal Implants

 

 

83,943

 

 

 

67,025

 

 

 

25.2

%

Biologics

 

 

41,351

 

 

 

40,319

 

 

 

2.6

%

Global Spine

 

 

263,115

 

 

 

228,232

 

 

 

15.3

%

Global Orthopedics

 

 

76,300

 

 

 

60,711

 

 

 

25.7

%

Net sales

 

$

339,415

 

 

$

288,943

 

 

 

17.5

%

Schedule of Components Net Sales

The table below presents product sales and marketing service fees, which are both components of net sales:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(U.S. Dollars, in thousands)

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Product sales

 

$

100,004

 

 

$

96,305

 

 

$

299,214

 

 

$

250,161

 

Marketing service fees

 

 

12,424

 

 

 

14,680

 

 

 

40,201

 

 

 

38,782

 

Net sales

 

$

112,428

 

 

$

110,985

 

 

$

339,415

 

 

$

288,943

 

Allowances for Expected Credit Losses

The following table provides a detail of changes in the Company’s allowance for expected credit losses for the three and nine months ended September 30, 2021 and 2020:

 

(U.S. Dollars, in thousands)

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Allowance for expected credit losses beginning balance

 

$

4,471

 

 

$

6,364

 

 

$

4,848

 

 

$

3,987

 

Impact of adoption of ASU 2016-13

 

 

 

 

 

 

 

 

 

 

 

1,120

 

Current period provision (recovery) for expected credit losses

 

 

590

 

 

 

(619

)

 

 

376

 

 

 

945

 

Write-offs charged against the allowance and other

 

 

(54

)

 

 

(309

)

 

 

(134

)

 

 

(647

)

Effect of changes in foreign exchange rates

 

 

(79

)

 

 

88

 

 

 

(162

)

 

 

119

 

Allowance for expected credit losses ending balance

 

$

4,928

 

 

$

5,524

 

 

$

4,928

 

 

$

5,524

 

Schedule of Changes in Contract Liability

(U.S. Dollars, in thousands)

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Contract liability beginning balance

 

$

10,971

 

 

$

13,851

 

 

$

13,851

 

 

$

 

Additions

 

 

 

 

 

 

 

 

 

 

 

13,851

 

Recoupment recognized in net sales

 

 

(3,071

)

 

 

 

 

 

(5,951

)

 

 

 

Contract liability ending balance

 

$

7,900

 

 

$

13,851

 

 

$

7,900

 

 

$

13,851

 

Other Contract Assets